Home/Filings/4/0001477932-23-007294
4//SEC Filing

Felix Lourdes 4

Accession 0001477932-23-007294

CIK 0001443863other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:30 PM ET

Size

5.3 KB

Accession

0001477932-23-007294

Insider Transaction Report

Form 4
Period: 2023-09-29
Felix Lourdes
DirectorCFO
Transactions
  • Award

    Common Stock, par value $0.001

    2023-09-29+2,85868,656 total
Footnotes (1)
  • [F1]These shares were issued to Ms. Felix pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Ms. Felix. As compensation for her services, Ms. Felix shall be issued, upon the last day of each fiscal quarter, provided Ms. Felix is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.75.

Issuer

BioCorRx Inc.

CIK 0001443863

Entity typeother

Related Parties

1
  • filerCIK 0001569735

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:30 PM ET
Size
5.3 KB